FDA Approved: CIMZIA — Supplemental Application (UCB, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Cimzia (certolizumab pegol) submitted by UCB, Inc. This action approves the changes described in the supplemental su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Crohn Disease
• Juvenile Idiopathic Arthritis
• Non-radiographic Axial Spondyloarthritis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

SUPPL AP for CIMZIA (CERTOLIZUMAB PEGOL)